ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 100 filers reported holding ENANTA PHARMACEUTICALS INC in Q2 2024. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $368,000 | – | 12,514 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 906,930 | $19,998,000 | 7.20% |
| McClain Value Management LLC | 186,850 | $4,120,000 | 3.51% |
| GREAT POINT PARTNERS LLC | 538,024 | $11,863,000 | 3.40% |
| SENZAR ASSET MANAGEMENT, LLC | 482,000 | $10,628,100,000 | 2.32% |
| ARMISTICE CAPITAL, LLC | 240,000 | $5,292,000 | 2.02% |
| EcoR1 Capital, LLC | 136,882 | $3,018,000 | 1.19% |
| Matarin Capital Management, LLC | 236,690 | $5,219,015,000 | 0.71% |
| Spark Investment Management LLC | 293,100 | $6,462,000 | 0.60% |
| HAYS ADVISORY LLC | 172,557 | $3,805,000 | 0.59% |
| Virtus ETF Advisers LLC | 23,292 | $514,000 | 0.38% |